Transfusion-Associated Circulatory Overload: A Clinical Perspective

Transfusion Medicine Reviews

Volumn 33, Issue 2, 2019, Pages 69-77

  Bosboom, Joachim J ^a   Klanderman, Robert B ^a   Migdady, Yazan ^b   Bolhuis, Barbara ^a   Veelo, Denise P ^a   Geerts, Bart F ^a   Murphy, Michael F ^c,d,e   Vlaar, Alexander P J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Critical care; Hematology; Hemovigilance; Transfusion; Volume overload

Indexed keywords

BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL OUTCOME; DIAGNOSTIC TEST; DISEASE SEVERITY; HUMAN; INCIDENCE; LUNG EDEMA; MORBIDITY; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; SYNDROME; SYSTEMATIC REVIEW; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; VASCULAR ENDOTHELIUM; ADVERSE EVENT; ALGORITHM; ERYTHROCYTE TRANSFUSION; FACTUAL DATABASE; HOSPITAL MORTALITY; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

BIOLOGICAL MARKER;

ALGORITHMS; BIOMARKERS; BLOOD TRANSFUSION; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; HOSPITAL MORTALITY; HUMANS; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; PULMONARY EDEMA; RISK FACTORS; TRANSFUSION REACTION; TREATMENT OUTCOME;

EID: 85062461008     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2019.01.003     Document Type: Review

References (77)

1. Popovsky, M.A., Audet, A.M., Andrzejewski, C. Jr., Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 12 (1996), 87–89.
2. Raval, J.S., Mazepa, M.A., Russell, S.L., Immel, C.C., Whinna, H.C., Park, Y.A., Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Vox Sang 108 (2015), 387–392.
3. Andrzejewski, C. Jr., Popovsky, M.A., Stec, T.C., Provencher, J., O'Hearn, L., Visintainer, P., et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects?. Transfusion 52 (2012), 2310–2320.
4. Roubinian, N.H., Hendrickson, J.E., Triulzi, D.J., Gottschall, J.L., Chowdhury, D., Kor, D.J., et al. Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm. Vox Sang 112 (2017), 56–63.
5. Clifford, L., Jia, Q., Yadav, H., Subramanian, A., Wilson, G.A., Murphy, S.P., et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 122 (2015), 21–28.
6. Narick, C., Triulzi, D.J., Yazer, M.H., Transfusion-associated circulatory overload after plasma transfusion. Transfusion 52 (2012), 160–165.
7. Li, G., Rachmale, S., Kojicic, M., Shahjehan, K., Malinchoc, M., Kor, D.J., et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 51 (2011), 338–343.
8. Bosboom, J.J., Klanderman, R.B., Zijp, M., Hollmann, M.W., Veelo, D.P., Binnekade, J.M., et al. Incidence, risk factors, and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population: a nested case-control study. Transfusion 58:2 (2018), 498–506.
9. Marshall, A.L., Levine, M., Howell, M.L., Chang, Y., Riklin, E., Parry, B.A., et al. Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal. J Thromb Haemost 14 (2016), 324–330.
10. Rana, R., Fernandez-Perez, E.R., Khan, S.A., Rana, S., Winters, J.L., Lesnick, T.G., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 46 (2006), 1478–1483.
11. Hendrickson, J.E., Roubinian, N.H., Chowdhury, D., Brambilla, D., Murphy, E.L., Wu, Y., et al. Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication. Transfusion 56 (2016), 2587–2596.
12. Muller, M.C., van Stein, D., Binnekade, J.M., van Rhenen, D.J., Vlaar, A.P., Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion 55 (2015), 164–175.
13. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2016. Available at: https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM598243.pdf.
14. Bolton-Maggs, P.H.B., Poles, D., et al. (eds.) on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2017 Annual SHOT Report, 2018.
15. Carson, J.L., Triulzi, D.J., Ness, P.M., Indications for and adverse effects of red-cell transfusion. N Engl J Med 377 (2017), 1261–1272.
16. Ellingson, K.D., Sapiano, M.R.P., Haass, K.A., Savinkina, A.A., Baker, M.L., Chung, K.W., et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion 57:Suppl. 2 (2017), 1588–1598.
17. U.S. Centers for Disease Control and Prevention, The National Healthcare Safety Network (NHSN) manual: biovigilance component v2.4., Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA Available at: http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf. (Accessed 25 January 2018)
18. Robillard, P., on behalf of the ISBT Working Party on Haemovigilance, Proposed standard definitions for surveillance of non infectious adverse transfusion reactions. Available at http://www.isbtweb.org/fileadmin/user_upload/Proposed_definitions_2011_surveillance_non_infectious_adverse_reactions_haemovigilance_incl_TRALI_correction_2013.pdf, 2013. (Accessed 30 October 2018)
19. Wiersum, J.C., on behalf of the International Society of Blood Transfusion Working Party on Haemovigilance, Transfusion-associated circulatory overload (TACO) Draft revised reporting criteria 2017. Available at: http://www.isbtweb.org/fileadmin/user_upload/TACO_reporting_criteria_April_2017_draft_for_validation.docx. (Accessed 30 October 2018)
20. Henneman, E.A., Andrzejewski, C. Jr., Gawlinski, A., McAfee, K., Panaccione, T., Dziel, K., Transfusion-associated circulatory overload: evidence-based strategies to prevent, identify, and manage a serious adverse event. Crit Care Nurse 37 (2017), 58–65.
21. Kanai, R., Iijima, T., Hashimoto, S., Nakazawa, H., Ohnishi, H., Yorozu, T., et al. Impact of immunoreactive substances contained in apheresis platelet concentrate on postoperative respiratory function in surgical patients receiving platelet transfusion: a prospective cohort study. Transfus Med 23 (2013), 344–350.
22. Clifford, L., Singh, A., Wilson, G.A., Toy, P., Gajic, O., Malinchoc, M., et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 53 (2013), 1205–1216.
23. Roubinian, N., Hendrickson, J.E., Gottschall, J., Triulzi, D., Kor, D.J., Chowdury, D., et al. Incidence and clinical characteristics of transfusion-associated circulatory overload (TACO) by using an electronic health record surveillance algorithm. Transfusion, 55, 2015, 41A.
24. Bosboom, J.J., Klanderman, R.B., Peters, A.L., van de Weerdt, E.K., Goudswaard, E.J., Binnekade, J.M., et al. The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers. Transfus Med 28:5 (2017), 363–370.
25. Bolton-Maggs, P.H.B., DP, The 2015 annual SHOT report on behalf of the Serious Hazards of Transfusion (SHOT) steering group. 2016.
26. Klanderman, R.B., Bosboom, J.J., Migdady, Y., Veelo, D.P., Geerts, B.F., Murphy, M.F., et al. Transfusion-associated circulatory overload—a systematic review of diagnostic biomarkers. Transfusion 59:2 (2019), 795–805.
27. Gajic, O., Gropper, M.A., Hubmayr, R.D., Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 34 (2006), S109–S113.
28. Carcano, C., Okafor, N., Martinez, F., Ramirez, J., Kanne, J., Kirsch, J., Radiographic manifestations of transfusion-related acute lung injury. Clin Imaging 37 (2013), 1020–1023.
29. Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18 (2016), 891–975.
30. Ware, L.B., Matthay, M.A., Clinical practice. Acute pulmonary edema. N Engl J Med 353 (2005), 2788–2796.
31. Boussuges, A., Blanc, P., Molenat, F., Burnet, H., Habib, G., Sainty, J.M., Evaluation of left ventricular filling pressure by transthoracic Doppler echocardiography in the intensive care unit. Crit Care Med 30 (2002), 362–367.
32. Monnet, X., Teboul, J.L., Transpulmonary thermodilution: advantages and limits. Crit Care, 21, 2017, 147.
33. Roubinian, N.H., Looney, M.R., Keating, S., Kor, D.J., Lowell, C.A., Gajic, O., et al. Differentiating pulmonary transfusion reactions using recipient and transfusion factors. Transfusion 57 (2017), 1684–1690.
34. Skeate, R.C., Eastlund, T., Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol 14 (2007), 682–687.
35. Andrzejewski, C., Popovsky, M.A., Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion 45 (2005), 1048–1050.
36. Andrzejewski, C. Jr., Casey, M.A., Popovsky, M.A., How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention. Transfusion 53 (2013), 3037–3047.
37. Blumberg, N., Heal, J.M., Gettings, K.F., Phipps, R.P., Masel, D., Refaai, M.A., et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 50 (2010), 2738–2744.
38. Parmar, N., Pendergrast, J., Lieberman, L., Lin, Y., Callum, J., Cserti-Gazdewich, C., The association of fever with transfusion-associated circulatory overload. Vox Sang 112 (2017), 70–78.
39. Wiedemann, H.P., Wheeler, A.P., Bernard, G.R., Thompson, B.T., Hayden, D., deBoisblanc, B., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354 (2006), 2564–2575.
40. Woodcock, T.E., Woodcock, T.M., Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108 (2012), 384–394.
41. Levick, J.R., Michel, C.C., Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 87 (2010), 198–210.
42. Collins, S.R., Blank, R.S., Deatherage, L.S., Dull, R.O., Special article: the endothelial glycocalyx: emerging concepts in pulmonary edema and acute lung injury. Anesth Analg 117 (2013), 664–674.
43. Dull, R.O., Cluff, M., Kingston, J., Hill, D., Chen, H., Hoehne, S., et al. Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction. Am J Physiol Lung Cell Mol Physiol 302 (2012), L816–L828.
44. Chappell, D., Jacob, M., Hofmann-Kiefer, K., Conzen, P., Rehm, M., A rational approach to perioperative fluid management. Anesthesiology 109 (2008), 723–740.
45. Shah, A., Brunskill, S.J., Desborough, M.J., Doree, C., Trivella, M., Stanworth, S.J., Transfusion of red blood cells stored for shorter versus longer duration for all conditions. Cochrane Database Syst Rev, 12, 2018, CD010801.
46. Donadee, C., Raat, N.J., Kanias, T., Tejero, J., Lee, J.S., Kelley, E.E., et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124 (2011), 465–476.
47. Refaai, M.A., Goldstein, J.N., Lee, M.L., Durn, B.L., Milling, T.J. Jr., Sarode, R., Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal. Transfusion 55 (2015), 2722–2729.
48. Hebert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med 340 (1999), 409–417.
49. Roubinian, N.H., Hendrickson, J.E., Triulzi, D.J., Gottschall, J.L., Michalkiewicz, M., Chowdhury, D., et al. Contemporary risk factors and outcomes of transfusion-associated circulatory overload. Crit Care Med 46:4 (2018), 577–585.
50. Corwin, H.L., Gettinger, A., Pearl, R.G., Fink, M.P., Levy, M.M., Abraham, E., et al. The CRIT study: Anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crit Care Med 32 (2004), 39–52.
51. Clifford, L., Jia, Q., Subramanian, A., Yadav, H., Schroeder, D.R., Kor, D.J., Risk factors and clinical outcomes associated with perioperative transfusion-associated circulatory overload. Anesthesiology 126 (2017), 409–418.
52. Menis, M., Anderson, S.A., Forshee, R.A., McKean, S., Johnson, C., Holness, L., et al. Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011. Vox Sang 106 (2014), 144–152.
53. Peng, Z., Pati, S., Potter, D., Brown, R., Holcomb, J.B., Grill, R., et al. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock 40 (2013), 195–202.
54. Bolton-Maggs, P., Poles, D., The 2015 annual SHOT report on behalf of the Serious Hazards of Transfusion (SHOT) steering group. 2016.
55. Lieberman, L., Maskens, C., Cserti-Gazdewich, C., Hansen, M., Lin, Y., Pendergrast, J., et al. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev 27 (2013), 206–212.
56. Geiger, T.L., Howard, S.C., Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?. Transfus Med Rev 21 (2007), 1–12.
57. Carson, J.L., Stanworth, S.J., Roubinian, N., Fergusson, D.A., Triulzi, D., Doree, C., et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 10, 2016, CD002042.
58. Ma, M., Eckert, K., Ralley, F., Chin-Yee, I., A retrospective study evaluating single-unit red blood cell transfusions in reducing allogeneic blood exposure. Transfus Med 15 (2005), 307–312.
59. Carson, J.L., Guyatt, G., Heddle, N.M., Grossman, B.J., Cohn, C.S., Fung, M.K., et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 316 (2016), 2025–2035.
60. Mazer, C.D., Whitlock, R.P., Fergusson, D.A., Hall, J., Belley-Cote, E., Connolly, K., et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 377 (2017), 2133–2144.
61. Holst, L.B., Haase, N., Wetterslev, J., Wernerman, J., Guttormsen, A.B., Karlsson, S., et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371 (2014), 1381–1391.
62. Karam, O., Demaret, P., Shefler, A., Leteurtre, S., Spinella, P.C., Stanworth, S.J., et al. Indications and effects of plasma transfusions in critically ill children. Am J Respir Crit Care Med 191 (2015), 1395–1402.
63. Karam, O., Tucci, M., Combescure, C., Lacroix, J., Rimensberger, P.C., Plasma transfusion strategies for critically ill patients. Cochrane Database Syst Rev, 12, 2013, CD010654.
64. Rygard, S.L., Holst, L.B., Perner, A., Blood product administration in the critical care and perioperative settings. Crit Care Clin 34 (2018), 299–311.
65. Gilliss, B.M., Looney, M.R., Gropper, M.A., Reducing noninfectious risks of blood transfusion. Anesthesiology 115 (2011), 635–649.
66. Alam, A., Lin, Y., Lima, A., Hansen, M., Callum, J.L., The prevention of transfusion-associated circulatory overload. Transfus Med Rev 27 (2013), 105–112.
67. Murphree, D., Ngufor, C., Upadhyaya, S., Madde, N., Clifford, L., Kor, D.J., et al. Ensemble learning approaches to predicting complications of blood transfusion. Conf Proc IEEE Eng Med Biol Soc 2015 (2015), 7222–7225.
68. Tseng, E., Spradbrow, J., Cao, X., Callum, J., Lin, Y., An order set and checklist improve physician transfusion ordering practices to mitigate the risk of transfusion-associated circulatory overload. Transfus Med 26 (2016), 104–110.
69. Sarai, M., Tejani, A.M., Loop diuretics for patients receiving blood transfusions. Cochrane Database Syst Rev, 2, 2015, CD010138.
70. Klanderman, R.B., Attaye, I., Bosboom, J.J., Veelo, D.P., Geerts, B.F., Vlaar, A.P.J., Transfusion-associated circulatory overload: a survey among Dutch intensive care fellows. Transfus Clin Biol 25 (2018), 19–25.
71. Becker, B.F., Chappell, D., Bruegger, D., Annecke, T., Jacob, M., Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 87 (2010), 300–310.
72. Murphy, E.L., Kwaan, N., Looney, M.R., Gajic, O., Hubmayr, R.D., Gropper, M.A., et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med 126 (2013), 357.e29–357.e38.
73. Piccin, A., Cronin, M., Brady, R., Sweeney, J., Marcheselli, L., Lawlor, E., Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010. Transfusion 55 (2015), 1223–1230.
74. Vossoughi, S., Perez, G., Whitaker, B.I., Fung, M.K., Stotler, B., Analysis of pediatric adverse reactions to transfusions. Transfusion 58:1 (2018), 60–69.
75. Li, N., Williams, L., Zhou, Z., Wu, Y., Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system. Transfusion 54 (2014), 1666–1672.
76. Karim, F., Moiz, B., Shamsuddin, N., Naz, S., Khurshid, M., Root cause analysis of non-infectious transfusion complications and the lessons learnt. Transfus Apher Sci 50 (2014), 111–117.
77. Gosmann, F., Norgaard, A., Rasmussen, M.B., Rahbek, C., Seeberg, J., Moller, T., Transfusion-associated circulatory overload in adult, medical emergency patients with perspectives on early warning practice: a single-centre, clinical study. Blood Transfus, 2017, 1–8.